Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHaemonetics Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | $1.25 | $1.30 | $1.27 |
| Q2 2026 | 6 | $1.15 | $1.18 | $1.17 |
| Q3 2026 | 2 | $1.29 | $1.36 | $1.33 |
| Q4 2026 | 2 | $1.35 | $1.43 | $1.40 |
| Q1 2027 | 4 | $1.37 | $1.44 | $1.41 |
| Q2 2027 | 4 | $1.27 | $1.34 | $1.31 |
| Q3 2027 | 4 | $1.49 | $1.57 | $1.54 |
| Q4 2027 | 4 | $1.53 | $1.61 | $1.58 |
| Q1 2028 | 3 | $1.53 | $1.62 | $1.58 |
Haemonetics Corp. Earnings Date And Information
Haemonetics Corp. last posted its earnings results on Thursday, February 5th, 2026. The company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of 338.97 M for the quarter and had revenue of 1.36 B for the year. Haemonetics Corp. has generated $3 earnings per share over the last year ($3.31 diluted earnings per share) and currently has a price-to-earnings ratio of 16.17. Haemonetics Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Haemonetics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q3 2026 | $1.27 | $0.96 | -0.31 | $331.92 M | $338.97 M |
| 11/06/2025 | Q2 2026 | $1.12 | $0.81 | -0.31 | $311.51 M | $327.32 M |
| 08/07/2025 | Q1 2026 | $1.01 | $0.71 | -0.3 | N/A | $321.39 M |
| 05/21/2025 | Q4 2025 | N/A | $1.17 | N/A | N/A | $330.60 M |
| 02/06/2025 | Q3 2025 | $1.18 | $0.75 | -0.43 | N/A | $348.54 M |
| 11/07/2024 | Q2 2025 | $1.09 | $0.66 | -0.43 | N/A | $345.51 M |
| 08/08/2024 | Q1 2025 | $1.03 | $0.75 | -0.28 | N/A | $336.17 M |
| 05/20/2024 | Q4 2024 | N/A | $0.40 | N/A | N/A | $343.29 M |
| 02/08/2024 | Q3 2024 | $0.97 | $0.62 | -0.35 | N/A | $336.25 M |
| 11/02/2023 | Q2 2024 | $0.94 | $0.49 | -0.45 | N/A | $318.18 M |
| 08/08/2023 | Q1 2024 | $0.73 | $0.81 | 0.08 | N/A | $311.33 M |
| 05/22/2023 | Q4 2023 | N/A | $0.58 | N/A | N/A | $304.42 M |
| 02/07/2023 | Q3 2023 | $0.79 | $0.65 | -0.14 | N/A | $305.30 M |
| 11/08/2022 | Q2 2023 | N/A | $0.65 | N/A | N/A | $297.49 M |
| 08/10/2022 | Q1 2023 | $0.53 | $0.39 | -0.14 | N/A | $261.46 M |
| 05/25/2022 | Q4 2022 | N/A | $0.19 | N/A | N/A | $265.00 M |
| 02/08/2022 | Q3 2022 | $0.75 | $0.45 | -0.3 | N/A | $259.77 M |
| 11/09/2021 | Q2 2022 | $0.63 | $0.29 | -0.34 | N/A | $239.90 M |
| 08/11/2021 | Q1 2022 | $0.47 | -$0.09 | -0.56 | N/A | $228.53 M |
| 05/26/2021 | Q4 2021 | N/A | -$0.22 | N/A | N/A | $225.03 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Haemonetics Corp. Earnings: FAQ's
In the previous quarter, Haemonetics Corp. (:HAE) reported $1.31 earnings per share (EPS) to beat the analysts' consensus estimate of $1.27 by $0.04.
The conference call for Haemonetics Corp.'s latest earnings report can be listened to online.
The conference call transcript for Haemonetics Corp.'s latest earnings report can be read online.
Haemonetics Corp. (:HAE) has a recorded annual revenue of $1.36 B.
Haemonetics Corp. (:HAE) has a recorded net income of $167.68 M.Haemonetics Corp. has generated $3.31 earnings per share over the last four quarters.
Haemonetics Corp. (:HAE) has a price-to-earnings ratio of 16.17 and price/earnings-to-growth ratio is 2.65.